Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stilgenbauer, Stephan, Prof, Eichhorst, Barbara, Prof, Schetelig, Johannes, Prof, Coutre, Steven, Prof, Seymour, John F, Prof, Munir, Talha, Prof, Puvvada, Soham D, MD, Wendtner, Clemens-Martin, Prof, Roberts, Andrew W, Prof, Jurczak, Wojciech, Prof, Mulligan, Stephen P, Prof, Böttcher, Sebastian, MD, Mobasher, Mehrdad, MD, Zhu, Ming, PhD, Desai, Monali, MD, Chyla, Brenda, PhD, Verdugo, Maria, MD, Enschede, Sari Heitner, MD, Cerri, Elisa, MD, Humerickhouse, Rod, MD, Gordon, Gary, MD, Hallek, Michael, Prof, Wierda, William G, MD
Published in The lancet oncology (01.06.2016)
Published in The lancet oncology (01.06.2016)
Get full text
Journal Article